A series of reports suggests the existence of altered calcium metabolism in diabetes mellitus (1, 2) . Calcium homeostasis is disturbed in animal models of diabetes mellitus, nevertheless the effects of diabetes mellitus on calcium metabolism in humans are controversial. Although some authors have found no significant alterations, apart from excessive urinary losses of calcium and phosphate (3), increased calcium absorption has been found after oral calcium loading in insulin-dependent diabetes mellitus (4), and slightly higher levels of total serum calcium have been found in non-insulin-dependent diabetes mellitus patients than in normal subjects (5) . On the other hand, it is well known that the incidence of secondary hyperparathyroidism and bone loss is reduced in diabetic Calcium absorption rate=100 
RESULTS
The daily dietary intake of major nutrients is shown in (Fig. 2) .
DISCUSSION
Loss of bone mass has been observed in both experimental (8) and insulin-dependent diabetes (9) but the issue is controversial in non-insulin-dependent diabetic patients; the etiology and pathophysiology of diabetic osteopenia are still unclear. One hypothesis of the etiology of diabetic osteopenia is that calcium and vitamin D metabolism is altered in diabetes (10). On the other hand, Heath et al. not markedly altered from normal in a large group of poorly controlled insulin-requiring diabetics who had massive glucosuria and small increases of urinary calcium excretion. In this current study, non-insulin-dependent diabetic patients had no remarkable abnormali ties of calcium metabolism. A slight increase of the ratio of urinary calcium to creatinine seems to indicate increased bone absorption in diabetic patients. We found that the small increase of urinary calcium excretion must not have been sufficient to perturb serum calcium and PTH and to affect intestinal absorption of calcium. The possibility remains that a subtle calcium metabolic abnormality might be demonstrable in some diabetic patients. Morii et al. (6) reported fewer bone changes in dialyzed diabetic patients than in dialyzed non-diabetic patients with chronic glomerulonephritis; this could be due to the lower concentration of carboxyl terminal region PTH in the blood. It has recently been demonstrated that secondary hyperparathyroidism developed more slowlier in dialyzed diabeteic patiens than in dialyzed patients without diabetes mellitus (7). Therefore, we tested the hypothesis that latent hypoparathyroidism might be found in diabetic patients before the onset of diabetic nephropathy. The response of parathyroid hormone to oral phosphate loading was reduced in diabetic patients with normal renal function compared to control subjects. We confirmed the results of a previous study in which no secondary increase in parathyroid hormone or 1,25(OH)2D3 was observed in diabetic patients, although serum calcium and phosphorus concentrations were slightly, but significantly, decreased (2) . These results may explain the low incidence of secondary hyperparathy roidism in dialyzed diabetic patients. In conclusion, slight abnormalities in several elements of calcium metabolism were observed in diabetic patients, but serum calcium homeostasis was maintained. 
